The Winship prostate cancer and genitourinary cancer teams include urologists, medical oncologists, radiation oncologists, advanced practice nurses and social workers. They work together to provide the most appropriate individualized approach to treating prostate cancer patients.
Our collaborative approach to care offers a number of benefits to our patients, including:
- Access to nationally and internationally renowned as well as community-based experts in prostate cancer.
- Weekly review of patient cases by the full team of experts.
- Coordinated scheduling for appointments among various specialties.
- Access to a nurse navigator to assist you throughout the treatment process.
- Access to support programs and groups for you and your caregivers.
- Availability of new treatment options within our clinical trials program.
Our prostate cancer program is located at Winship Cancer Institute (Clifton campus), Emory Saint Joseph's Hospital, Emory University Hospital Midtown and Emory Johns Creek Hospital.
Request an Appointment
If you have been diagnosed with prostate cancer, we are ready to help you. Call us at 1 (888) 946-7447 or (404) 778-1900 to request an appointment with a prostate cancer specialist. Winship experts are available to provide a second opinion.
We understand that this is a very stressful time. We welcome your questions and requests for help.
Most men will not experience any symptoms of prostate cancer if it is caught early. However, some men do, and these symptoms may include the following:
- A need to urinate frequently, especially at night
- Difficulty starting urination or holding back urine
- Weak or interrupted flow of urine
- Painful or burning urination
- Difficulty in having an erection
- Painful ejaculation
- Blood in urine or semen
- Frequent pain or stiffness in the lower back, hips, or upper thighs
Men who experience any of these symptoms should speak to their doctor.
These are some of the tests that may be used to confirm a diagnosis:
Prostate Specific Antigen (PSA) Tests: a blood test is used to assess the level of PSA in the blood. A higher-than-normal level of PSA might indicate a problem with the prostate, including cancer.
Digital Rectal Exam (DRE): a physician inserts a lubricated, gloved finger into the rectum to feel for abnormalities of the prostate.
An abnormal age-adjusted prostate specific antigen (PSA) test or abnormal digital rectal (DRE) exam is an indication of prostate cancer, but does not mean cancer is present. Abnormal findings should be followed by a biopsy of the prostate cells to determine whether they are in fact cancerous.
Biopsy: a biopsy is a procedure in which a sample of tissue is taken from the prostate and then viewed under a microscope to check for abnormalities.
Prostate Health Index (phi): still being studied, phi is a new, more precise blood test that better distinguishes an aggressive cancer from a low-risk cancer.
That's why it is important to make an informed decision about the best treatment with your healthcare team.
Older patients with health problems and those with slow-growing cancers often treat prostate cancer as a chronic or long-term disease and take a disease management approach with just watchful waiting.
Sometimes combinations of therapies like radiation therapy following surgery, or external radiation following brachytherapy implants is the best way to go.
- Radical Perineal Prostatectomy
- Robotic Prostatectomy
- Open Retropubic Prostatectomy
Radiation therapy options:
- Brachytherapy (internal radiation therapy)
- External beam radiation therapy
- Three-dimensional conformal radiation therapy
- Intensity modulated radiation therapy
- Proton beam therapy available at Emory Proton Therapy Center.
Hormone therapy (also called androgen deprivation therapy) may be used if surgery or radiation is not an option. Chemotherapy is sometimes considered if prostate cancer has spread outside the prostate gland and hormone therapy is no longer effective.
Consider talking with your doctor about participating in a clinical trial at Winship. Through these trials, you may have access to treatments for prostate cancer that are not widely available.
Supportive Oncology Care
In addition to delivering the highest quality medical care, we recognize the importance of the psychological and emotional aspects of living with a cancer diagnosis and of dealing with treatment. Our supportive oncology team address these issues in a timely manner with additional support from counselors, nurse navigators, dietitians and social service professionals.
Some men may experience sexual changes after treatment for prostate cancer. Winship experts worked with colleagues from other institutions to create an online, tailored interactive program to support men and their partners on their journey toward sexual recovery after prostate cancer treatment. Visit the Movember Foundation's Sexual Recovery Program website to learn more.
Your Treatment Team
- Physician Diagnosticians
- Nurse Navigators
- Adv Practice
- Support Services
- Clinical Trials
- As part of the genitourinary oncology team, Dr. Carthon treats patients with prostate, bladder, and renal cancers and other genitourinary malignancies.
- Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
- (404) 778-1900
- Dr. Goldman practices general medical oncology and hematology with a focus on treating patients with genitourinary cancer at Emory Saint Joseph's Hospital.
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
- (404) 778-1900
- Dr. Issa's clinical and research interests include urological oncology, stones, endourology, minimally invasive surgery, clinical outcomes, and healthcare economics and operational strategies.
- Professor, Department of Urology, Emory University School of Medicine
- (404) 778-4898
- A medical oncologist with a major interest in nutrition and cancer prevention, Dr. Kucuk mainly treats patients with prostate, bladder and kidney cancer.
- Professor and Correll Chair in Genitourinary Cancer, Department of Hematology and Medical Oncology, Emory University School of Medicine
- (404) 778-1900
- Dr. Master is a renowned national expert in the surgical treatment of kidney cancer particularly a complex variety that extends into the main blood vessels and the heart.
- Director of Integrative Oncology and Survivorship, Winship Cancer Institute of Emory University
- (404) 778-4898
- Dr. Newsome's clinical specialties include uterine fibroid embolization, ablative and catheter-directed treatments for cancer, among others.
- Division Director and Chief, Interventional Radiology and Image-Guided Medicine, Emory University Hospital Midtown
- (404) 778-4747
- Dr. Patel specializes in the treatment of genitourinary and gastrointestinal malignancies as well as the use of high-dose rate brachytherapy, stereotactic body radiation therapy and proton therapy.
- Associate Professor, Department of Radiation Oncology, Emory University School of Medicine
- (404) 778-3473